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Abstract
Background: Activation of amoeboid microglial cells (AMC) and its related inflammatory response have been
linked to the periventricular white matter damage after hypoxia in neonatal brain. Hypoxia increases free ATP in
the brain and then induces various effects through ATP receptors. The present study explored the possible
mechanism in ATP induced AMC activation in hypoxia.
Results: We first examined the immunoexpression of P2X4, P2X7 and P2Y12 in the corpus callosum (CC) and
subependyma associated with the lateral ventricles where both areas are rich in AMC. Among the three purinergic
receptors, P2X4 was most intensely expressed. By double immunofluorescence, P2X4 was specifically localized in AMC
(from P0 to P7) but the immunofluorescence in AMC was progressively diminished with advancing age (P14). It was
further shown that P2X4 expression was noticeably enhanced in P0 day rats subjected to hypoxia and killed at 4, 24, 72
h and 7 d versus their matching controls by double labeling and western blotting analysis. P2X4 expression was most
intense at 7 d whence the inflammatory response was drastic after hypoxia. We then studied the association of P2X4
with cytokine release in AMC after hypoxic exposure. In primary microglial cells exposed to hypoxia, IL-1b and TNF-a
protein levels were up-regulated. Blockade of P2X4 receptor with 2’,3 ’-0-(2, 4, 6-Trinitrophenyl) adenosine 5’-
triphosphate, a selective P2X1-7 blocker resulted in partial suppression of IL-1b (24% vs hypoxic group) and TNF-a
expression (40% vs hypoxic group). However, pyridoxal phosphate-6-azo (benzene-2, 4-disulfonic acid) tetrasodium salt
hydrate, a selective P2X1-3, 5-7 blocker did not exert any significant effect on the cytokine expression.
Conclusions: It is concluded that P2X4 which is constitutively expressed by AMC in postnatal rats was enhanced
in hypoxia. Hypoxia induced increase in IL-1b and TNF-a expression was reversed by 2’,3 ’-0-(2, 4, 6-Trinitrophenyl)
adenosine 5’-triphosphate suggesting that P2X4 mediates ATP induced AMC activation and its production of
proinflammatory cytokines.
Background
Perinatal brain injury occurs in approximately 4 per
1000 births [1] with exposure to hypoxic-ischemic
insults and premature delivery (before 37 weeks of
gestation) as major contributing factors. The defining
feature of neuropathology in hypoxia and ischemia ence-
phalopathy is the injury susceptibility of the periventri-
cular white matter (PWM) [2]. It has been reported
recently that the preponderant amoeboid microglial cells
(AMC) and their activation is associated with the peri-
ventricular white matter damage (PWMD) in neonatal
brain after hypoxia [3,4]. AMC activation in hypoxia is
f o l l o w e db yi n f l a m m a t o r yr e s p o n s ea f f e c t i n gt h ea x o n s
and oligodendrocytes [4], but the underlying mechanism
leading to AMC activation has remained uncertain.
Burnstock [5] proposed the roles of nucleotides as
neurotransmitters. Thus, during inflammation or cellular
damage affecting the neurons, the adenosine 5’-tripho-
sphate (ATP) level in the extracellular spaces is
described to be markedly increased [6,7]. It has been
reported that ATP and its receptor were involved in
cell-to-cell communication in physiological and patho-
physiological conditions [8]. We have shown previously
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vation [9]. It has been reported that on exposure to
ATP, microglia exhibited changes in its electrophysiolo-
gical properties [10] and increased expression of cyto-
kines in BV2 microglial cell line as well as the primary
cultured microglial cells [9,11,12]. Microglial cells are
known to express P2X receptors [13]. ATP would then
induce various effects through its receptors [8,11,12]. As
a group of membrane cation-selective receptor channels,
P2X receptors interact with extracellular ATP [13]. It
has been reported that ATP elicits discrete currents of
P2X4R on microglia/macrophages [14]. In the latter,
P2X4 receptors are involved in microglial activity in
some pathological conditions. For example, the upregu-
lation of P2X4 in microglia appears to play a crucial
role in contributing to neuropathic pain which has a
close relationship with the inflammation [15]. Suppres-
sion of P2X4 expression by 2’,3 ’-0-(2, 4, 6-Trinitrophe-
nyl) adenosine 5’-triphosphate) (TNP-ATP) and
pyridoxal phosphate-6-azo (benzene-2, 4-disulfonic acid)
(PPADS) prevents tactile allodynia [16]. Guo [17] had
reported that P2X4 expression in experimental autoim-
mune encephalomyelitis (EAE) was confined to the
macrophage cells that infiltrated from the blood,
furthermore, P2X4 expression reflects the inflammation
response during EAE. Taken together, the above studies
strongly suggest that P2X4 expression in microglial
cells/macrophages may take part in the inflammatory
response in injuries of the central nervous system.
The neuroprotective action exerted by TNP-ATP and
PPADS together with the possible use of the purinergic
antagonists in the pharmacological treatment of mor-
phine induced migration of microglial [18] and oxygen/
glucose deprivation [19-21] have been considered. Wixey
and co-workers [22] have reported increased expression
of ATP receptor P2X4 in microglial cells at 7 days after
3-day old postnatal rats were exposed to hypoxia-ische-
mia. However, the expression of ATP receptor and its
changes after hypoxia in AMC in postnatal age, as well as
the relationship of P2X4 and cytokine expression after
hypoxia has remained to be explored.
It is suggested from the above studies that both ATP
and ATP receptors may be jointly involved in microglial
activation. The present study sought to explore the pos-
sible mechanism of ATP induced AMC activation after
hypoxia in the periventricular white matter and the
roles of ATP receptors especially P2X4 in regulating
hypoxia induced cytokine expression in PWMD.
Results
P2X4, P2X7 and P2Y12 immunoexpression in AMC in
postnatal rat brain
By immunofluorescence double labeling, P2X4 AMC
were distributed preferentially in the CC and
subventricular zone (SVZ) in P3 rat brain (Figure 1Aa-
c). There was a total coincidence between OX-42 and
P2X4 in the AMC either in the CC (Figure 1Ba-c) or
SVZ (Figure 1Ca-c). P2X7 and P2Y12 immunopositive
cells were also found in the CC (Figure 1D-E) but the
immunofluorescence intensity was noticeably less in
comparison with P2X4 immunofluorescence. Further-
more, the frequency of AMC colabeled with P2X7 was
lower compared to P2X4; even fewer AMC were posi-
tive for P2Y12. P2X7 and P2Y12-immunoreactive cells
were confirmed to be the AMC as shown by double
immunofluorescence labeling with OX42 (Figure 1D-E).
P2X4 expression changes in AMC in P0 hypoxic rats
In P0 rats subjected to hypoxic exposure for 3 h and
sacrificed at 4, 24, 72 h and 7, 14d, double immuno-
fluorescence labeling showed the expression changes of
P2X4 expression in AMC with advancing time. The
fluorescence intensity and frequency of P2X4 positive
cells were noticeably enhanced when compared with the
respective matching controls at 4 h (Figure 2A-B), 24 h
(Figure 2C-D), 72 h (Figure 2E-F), 7 d (Figure 2G-H),
and 14 d (Figure 2I-J).
W e s t e r nb l o ta n a l y s i ss h o w e dt h a tP 2 X 4p r o t e i n
expression level of the callosal tissue rich in AMC was
up-regulated at 4, 24, 72 h and 7 d after hypoxia when
compared with the matching controls (Figure 3). At 14
d after hypoxia, P2X4 expression level was comparable
to that of the matching controls (Figure 3).
TNF-a, IL-1b and P2X4 expression after hypoxia and
blockade with PPADS/TNP-ATP in primary microglial cells
Following hypoxia, TNF-a and IL-1b mRNA expression
in microglial cells in vitro was significantly increased.
Additionally, by western blotting analysis, IL-1b and
TNF-a protein expression was significantly increased
following hypoxia treatment [9]. We next investigated
the link between the IL-1b,T N F - a protein expression
and P2X4 in hypoxic microglia. Primary microglial cells
were blocked with PPADS, a blocker of P2X1-3, 5-7.
This resulted in decreased IL-1b and TNF-a protein
expression after hypoxic exposure. A more drastic
decrease in TNF-a (Figure 4) and IL-1b (Figure 4) pro-
tein expression was observed in hypoxic microglial cells
blocked with TNP-ATP.
Morphological changes of AMC after hypoxia and
following treatment with PPADS/TNP-ATP
Following hypoxia, the external morphology of primary
culture AMC underwent changes. The cell body of
hypoxic microglia appeared to be more rounded. After
PPADS treatment, the cells emitted long extending pro-
cesses. Indeed, the cells appeared more ramified in
TNP-ATP treated hypoxic microglial cells (Figure 5).
Li et al. BMC Neuroscience 2011, 12:111
http://www.biomedcentral.com/1471-2202/12/111
Page 2 of 11Figure 1 P2X4, P2X7 and P2Y12 immunoexpression in AMC in postnatal rat brain. By immunofluorescence labeling, P2X4 is colocalized
with OX42 in the amoeboid microglial cells. Colocalization of OX42 and P2X4 in cells (arrows) is seen in the corpus callosum and subventricular
zone (Aa-c, Scale bar = 100 μm). Immunopositive cells are round and have a typical morphology of amoeboid microglial cells (B/Ca-c. Scale bar
=2 0μm). The amoeboid microglial cells exhibit a stronger P2X4 immunoreactivity compared with that of P2X7 and P2Y12 (D/Ea-c, Scale bar =
20 μm.).
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Microglial cells are motile immune-competent cells
which assume a highly branched morphology in mature
stage referred to as ramified microglial cells. In the early
brain development, the microglial cells show a different
phenotype characterized by a round or oval cell body
with a variable number of stout processes and are
referred to as the AMC [23]. They are preferentially
located in the subcortical white matter notably the CC
and the SVZ. The cells monitor the brain parenchyma
under physiological conditions at different stages.
Recently, it has been reported [4] that AMC activation
is involved in PWMD after hypoxia in the brain through
the secretion of proinflammatory cytokines by the cell
type. In this study, we have focused on the mechanism
of AMC activation after hypoxia. It was hypothesized
Figure 2 P2X4 immunoexpression in P0 rats subjected to hypoxia (Hy) at different time points. P0 rats subjected to Hy and sacrificed at
4 (Hy4 h), 24 (Hy24 h), 72 (Hy72 h), 7D (Hy7 d) and 14D (Hy14 d). Note P2X4 immunofluorescence in amoeboid microglial cells overlapping
with OX42 fluorescence is noticeably enhanced in the hypoxic rats Hy4 h (A/Ba-c), Hy24 h (C/Da-c), Hy72 h (E/Fa-c), and Hy7 d (H/Ia-c) when
compared with the matching controls (Con4 h, Con24 h, Con72 h, Con7 d and Con14d). Scale bar = 20 μm.
Li et al. BMC Neuroscience 2011, 12:111
http://www.biomedcentral.com/1471-2202/12/111
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their activation in hypoxia. In this connection, we have
reported previously that AMC express voltage gated
potassium channel Kv1. 2 which may be linked to
hypoxia and lipopolysaccharide induced AMC activation.
Additionally, ATP can induce Kv1. 2 expression and
cytokine release in AMC after hypoxia [9]. It is well
documented that free ATP is increased in hypoxic brain
tissue [24,25]. It was surmised that ATP may be an
important stimulus for microglial activation that may
exacerbate the brain damage. This takes into
consideration of the recent evidence that AMC are
directly involved in PWMD causing damage to both the
axons and myelin forming cells, oligodendrocytes [4,26].
Here, we provide evidence of the mechanism of hypoxia
induced AMC activation after hypoxia, which is via ATP
receptors.
P2X4 expression during development
There is strong evidence indicating that neuronal degen-
eration in the brain typically develops as a result of
microglial activation which is critically dependent on
Figure 3 P2X4 expression by western blotting in P0 rats subjected to hypoxia (Hy) at different time points in corpus callosum (CC).A .
P2X4 expression after hypoxia in P0 rats. P0 rats exposed to Hy and sacrificed at 4 (Hy4 h), 24 (Hy24 h), 72 (Hy72 h), 7D (Hy7 d) and 14D (Hy14
d). It shows P2X4 (60 kDa) and b-actin (42 kDa) immunoreactive bands, respectively. P2X4 expression in CC after hypoxia is noticeably enhanced
in the hypoxic rats at Hy4 h, Hy24 h, Hy72 h and Hy7 d when compared with the matching controls. B. Quantitative analysis of P2X4 expression
after hypoxia in CC. P2X4 protein express in the CC at 3, 24, 72h, 7 and 14 d after the hypoxic exposure in P0 rats. In bar graph, relative P2X4
protein levels were normalized to b-actin levels in control and hypoxia groups. Data are mean ± SD, n = 6. *P <0 .0 5o r* * P < 0. 01 hypoxia vs.
with their corresponding controls.
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purinoceptor and metabolic purinoceptor. Ionotropic
purinoceptors include P2X4 and P2X7, while metabolic
purinoceptors include P2Y12. Ramified microglial cells
express both ionotropic and metabolic purinoceptors
[27]. However, expression of ATP receptors in AMC
especially during development has remained to be
explored. Indeed, there is only a modicum of informa-
tion related to this by Wixey et al [22], who reported
expression of P2X4 expression in microglial cells in
postnatal rats at 10 days of age. More evidence for this
would be desirable to confirm P2X4 localization in the
AMC with typical morphology during development. We
have confirmed this by double immunofluorescence
labeling with OX-42 which demonstrated that P2X4 was
indeed localized in AMC, but also extended the fact
that P2X7 and P2Y12 were also localized in the same
cell type but the expression was evidently less intense. It
is striking that P2X4 is the predominant ATP receptor
in the AMC in the developing brain while P2X7 and
P2Y12 are detected in only a subpopulation of AMC.
This differs from the ramified microglial cells in the
adult rat brain [27]. In adult rat brain, P2X4 has been
reported to be involved in some pathological conditions
[28-30]. It is speculated that P2X4 may be actively
involved in the AMC activation in early brain
development whose function may be related to the sus-
ceptibility in injury of the PWM in hypoxia.
Expression of P2X4 in AMC after hypoxia in postnatal rats
It has been reported that in some pathological condi-
tions, expression of P2X4-receptor (P2X4R) a subtype of
ionotropic purinoceptor increases in microglia, but not
in neurons or astrocytes [28-30]. Additionally, P2X4
appears to play a crucial role in contributing to neuro-
pathic pain [15,28,30] and P2X4 expression reflects the
inflammation response during EAE [17]. Up-regulation
of P2X4 expression was also detected in microglial cells
at 7 days in a 3-day old rat’sh y p o x i a - i s c h e m i am o d e l
[22], but the expression changes of P2X4 with time after
hypoxia in P0 rats in AMC have remained to be fully
clarified.
The present results have shown that increased P2X4
expression in AMC was sustained from 4 h to 7 d after
hypoxia in newborn rats. This is evidenced by double
immunofluorescence labeling of P2X4 in AMC at differ-
ent time points. This is consistent with the western blot
analysis which shows a significant increase in P2X4
expression in the callosal tissue when compared with
the matching controls. It is to be noted that there is a
significant increase in P2X4 expression at 72 h and 7 d
after hypoxia. Wixey et al [22] reported increased P2X4
Figure 4 Quantitative analysis of TNF-a and IL-1b protein expression in the primary cultured AMC after the hypoxic exposure coupled
with PPADS or TNP-ATP treatment. A. Western blotting of TNF-a at 30 kDa, IL-1b at 17 kDa immunoreactive bands, respectively. B-C. Bar
graphs showing significant changes in the optical density of TNF-a and IL-1b, respectively, following hypoxic exposure when compared with
their corresponding controls (mean ± SD). *P < 0. 01 Control, PPADS, TNP-ATP groups vs. hypoxic group,
ΔP <0 .0 5o r
ΔΔP <0 .0 1vs. TNP-ATP
group. By western blotting analysis, IL-1b and TNF-a protein expression was significantly increased following hypoxia treatment. Blockade with
PPADS, a blocker of P2X1-3, 5-7 resulted in decreased IL-1b and TNF-a protein expression after hypoxic exposure. A more drastic decrease in
TNF-a and IL-1b protein expression was observed in hypoxic microglial cells blocked with TNP-ATP.
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Page 6 of 11Figure 5 P2X4 expression and phenotype change in primary cultured amoeboid microglial cells after the hypoxic exposure with
PPADS or TNP-ATP treatment. By immunofluorescence labeling, P2X4 is colocalized with OX42 in the primary cultured microglial cells (Aa-c,
Scale bar = 20 μm). Following hypoxia, the phenotype of primary cultured AMC undergoes alteration (Ba-c, Scale bar = 20 μm) in which the cell
body becomes rounded; however, the cells show long extending processes after treatment with PPADS (Ca-c, Scale bar = 20 μm). A more
obvious change was found in hypoxic microglial cells treated with TNP-ATP (Da-c, Scale bar = 20 μm).
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Page 7 of 11expression at 7 d only after hypoxia-ischemia injury.
Here we showed that P2X4 expression was increased at
an early time point after hypoxia in P0 rats. The discre-
pancy may be due to different experimental animal
models used. In our study, we have used P0 rats sub-
jected to hypoxic exposure. A marked increase in P2X4
expression was detected at P7 after hypoxia. Interest-
ingly, this is the time point whence severe inflammatory
response was noted in the PWM in a perinatal rats’
hypoxic model [26].
A tl a t e rt i m ep o i n t se .g .a t1 4da f t e rh y p o x i a ,t h e
P2X4 expression was comparable to that in the match-
ing normal controls. This suggests that while P2X4
expression in AMC is acute in onset in response to
hypoxia, it subsides with time. A possible explanation
for this may be that at early stage of hypoxia neuronal
damage is more severe and, hence, extracellular ATP
level is high. The concentration of free ATP in the brain
may decrease at the later stage of hypoxia when cellular
repair and regeneration are in progress. We have
reported previously that a higher ATP concentration
would elicit BV-2 microglial cell activation more pro-
foundly [9]. A sudden surge in free ATP is expected in
the acute and early phase of hypoxia. This would induce
a stronger P2X4 expression at the early stage than the
later stage of hypoxia. It has been reported that ramified
m i c r o g l i ar e c r u i t m e n tt ot h es i t eo fi s c h e m i aa n d
hypoxia impairment is associated with cellular loss and
P2X4-R are involved in cellular activation [19-21]. In
this regard, the neuroprotective actions exerted by TNP-
ATP and PPADS and the possible use of purinergic
antagonist in the pharmacological treatment of oxygen/
glucose deprivation have been considered [19-21,31].
Although P2X4 expression and inflammation after
hypoxia-ischemia in the rat brain have been investigated
after intraperitoneally injection of minocycline [22], the
use of selected P2X4 antagonists to suppress AMC acti-
vation and associated inflammation in the postnatal
brain after hypoxia has not been explored.
P2X4 induced AMC activation and release of cytokines
after hypoxia
There is ample evidence to suggest that ATP is involved
in microglial activation specifically in the ramified phe-
notype in the adult brain [24,25,31]. On the other hand,
the role of ATP in AMC activation especially the
mechanisms in hypoxia have remained elusive. This is
an important issue since AMC activation can lead to
PWMD in perinatal hypoxia. During hypoxia damage
affecting the neurons, the ATP level in the extracellular
spaces is described to be markedly increased [24,25].
Here we detected an obvious increase in P2X4 expres-
sion in 7 d rats after hypoxia at P0, when the inflamma-
tory response is most severe in this model [26]. Hence,
we hypothesize that P2X4 mediates the inflammatory
response in AMC subjected to hypoxia.
In the present study, primary microglial cells were
subjected to hypoxia. Our results showed that after
hypoxic exposure, IL-1b and TNFa protein expression
was increased in primary microglial cells suggesting the
activation of the cells. Along with this, the external
microglial morphology also was altered. Additionally,
increased P2X4 expression in primary microglial cell
after hypoxia was also detected by confocal microscopy.
We reported previously microglial activation after ATP
exposure. Both IL-1b and TNF-a mRNA and protein
levels were significantly increased after ATP treatment
[9]. It was therefore concluded that ATP can induce
microglial activation after hypoxia. In the present study,
we confirmed that expression of ATP receptor P2X4
both in vivo and in primary cultured AMC.
Hypoxia induced AMC activation as reflected by
increased production of TNF-a and IL-1b was suppressed
following the application of PPADS and TNP-ATP, the
selective blocker of P2X1-3, 5-7 and P2X1-7 [16], respec-
tively. It is noteworthy that the external morphology of
AMC returned to its resting state after treatment with
both blockers suggesting that the latter can reduce activa-
tion of microglial cells. It is further suggested that P2X4
can regulate hypoxia induced AMC activation and take
part in increased production of IL-1b and TNFa after
hypoxia. Targeting P2X4 with its specific blocker may
therefore be a potential therapeutic strategy to attenuate
neuroinflammation in hypoxic brain in which high levels
of ATP are expected to inundate the brain tissues.
The expression of TNFa can be blocked partially by
PPADS; however, a more obvious suppression was
exerted by TNP-ATP. Expression of IL-1b was sup-
pressed only by TNP-ATP indicating its closer relation-
ship to P2X4 expression in hypoxic microglia. The
precise modulating mechanism of IL-1b and TNF-a
expression after hypoxia awaits further investigation.
Conclusion
We show here that AMC express ATP receptors P2X4,
P2X7 and P2Y12 notably the first named receptor in
hypoxia in neonatal brain. It is suggested that the preva-
lent ATP receptor P2X4 may be linked to regulation of
AMC activation for production of proinflammatory
cytokines especially in altered environment such as
hypoxia. Therefore, unraveling the purinergic receptors,
specifically P2X4 in its modulatory mechanisms for
AMC activation may provide new therapeutic strategies
for hypoxia induced injuries in the postnatal brain.
Methods
The experimental procedures used in this study were
approved by the Kunming Medical College Institutional
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Page 8 of 11Animal Care and Use Committee. In the handling and
care of all animals, the International Guiding Principles
for Animals Research, as stipulated by the Council for
International Organizations of Medical Sciences (1985)
and as adopted by the Laboratory Animal Centre,
Kunming Medical College, Yunnan, China, were fol-
lowed. All efforts were made to minimize the number of
rats used and their suffering.
P2X4 immunoexpression in amoeboid microglial cells in
postnatal rats
Sprague Dawley (SD) rats at postnatal (P) 3 days (d)
(P3) (n = 6) were used. The rats were anesthetized with
3% sodium pentobarbital (100 mg/kg) injected intraperi-
toneally and sacrificed by perfusion transcardially first
with Ringer’s solution, followed by fixation with 2% par-
aformaldehyde in 0. 1 M phosphate buffer. The brain
was removed, post-fixed for 3 h in the same fixative,
and then cryoprotected in 15% sucrose for 24 h. Frozen
sections at 30 μm thickness were cut coronally through
t h ef o r e b r a i nw i t hac r y o s t a t( L e i c am o d e lC M 3 0 5 0 ,
Germany) and mounted onto gelatin-coated slides and
stored at -20°C until use.
For ATP receptor immunofluorescence and double label-
ing with mouse anti-OX42 (CD11B) monoclonal antibody
(1: 200, Milipore, Cat: CBL1512, USA), frozen coronal sec-
tions of the brain containing the CC rich in AMC were
incubated with 10% horse serum (Vector, Cat: S-2000,
USA.) for 40 min and rinsed in phosphate buffered saline
(PBS) to block nonspecific protein. The sections were then
incubated at 22-24°C with rabbit anti-P2X4 polyclonal pri-
mary antibody (1: 200, Alomone, Cat: APR-002, Yiselie),
rabbit anti-P2X7 polyclonal primary antibody (1: 200, Alo-
mone, Cat: APR-004, Yiselie), and rabbit anti-P2Y12 poly-
clonal primary antibody (1: 200, Alomone, Cat: APR-012,
Yiselie) overnight. Subsequent antibody detection was car-
ried out with FITC-conjugated donkey anti-rabbit IgG (1:
200, Millipore, Cat: AP182F, USA) for 1 h. After washing
with PBS, the sections were incubated with Cy3-conjugated
goat anti-mouse IgG (1: 200, Millipore, Cat: AP124C, USA)
for OX42, a marker for microglial cells [32] for 1 h. The
sections were then washed in PBS and mounted in a fluor-
escent mounting medium (DAKO Cytomation, Denmark).
Cellular colocolization was then examined in a confocal
microscope (Zeiss, LSM510 Axiovert 200 M, Germany).
Hypoxic exposure of postnatal rats
P0 rats (n = 60) were kept in a hypoxia chamber (Chi-
nese Utility Model Patent; patent number: ZL2010 2
01877. 4) filled with a gas mixture of 5% oxygen and
95% nitrogen for 3. 5 h. The rats were allowed to
recover under normoxic conditions and killed at 4, 24,
72 h, 7, and 14 d (n = 6 at each time point for immuno-
fluorescence or western blotting analysis) after hypoxia.
For normoxic matching control, the rats (n = 6 for each
time point for immunofluorescence or western blotting
analysis) were kept outside of the chamber. For immu-
nofluorescence study, the rats were sacrificed and the
tissues processed as described above. Coronal brain sec-
tions were processed for P2X4 immunohistochemistry
and immunofluorescence double labeling. For western
blotting, the tissue was removed and stored at -80°C
until use. The protein was extracted using a protein
extraction kit according to the manufacturer’sp r o t o c o l .
Western blotting was used to detect the expression
levels of P2X4.
Primary microglial cell culture
Highly purified microglial cultures were prepared from a
modified method [33,34] using P2-P3 SD pups. The
meninges were carefully removed from the brain and
the cortical tissue was minced with a sterile scalpel
blade and digested with 0. 25% trypsin/EDTA (HyClone,
SH30042. 01, USA) for 15 min at 37°C. Five milliliters
of Dulbecco’s modified Eagle’s medium high glucose
(DMEM) (HyClone, Cat: SH30243. 01B, USA) supple-
mented with 10% charcoal-stripped fetal bovine serum
(HyClone, Cat: SV30087. 02, USA) and 1% penicillin/
streptomycin (HyClone, Cat: SV30010, USA)(P/S, 100
U/mL penicillin, 100 lg/mL streptomycin, P/S) (DMEM
complete) were added to the tissue on ice, and the tis-
sue was triturated with a 5 ml pipette several times,
allowing the tissue clumps to settle. The supernatant
was removed to a clean 50 ml conical tube on ice
between triturations. Triturations were repeated until no
tissue clumps were observed. The final volume was
diluted to 25 mL medium and centrifuged at 3000 rpm
for 5 min. The supernatant was discarded and cells
resuspended in medium. A small aliquot of cells was
stained for trypan blue exclusion and cells were plated
at 10 million cells per 75 cm
2 flask. Cultures were main-
tained at 37°C and 5% CO2. The medium was changed
the first time after 24 h, and then twice a week. After 10
days the bottom of flask was confluent with astrocytes
and microglia. The flasks containing a mixture of astro-
cytes and microglia were shaken by hand for 2 min.
Microglial cells in the medium were plated into 75 cm
2
flask or cover slip for different use. After 15 min, the
medium was changed and the cells adherent to the bot-
tom will be kept in the incubator for 24 h until use.
About 98% of cells in cultures were identified to be
microglia by staining with OX42 antibody, a marker for
the microglial CR3/CD11B receptor.
IL-1b and TNF-a expression in primary culture microglial
cells after hypoxia
Primary culture microglial cells were seeded in a 75 cm
2
TC-treated culture flasks. They were then kept in the
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gen, 5%CO2 and 92% nitrogen at 37°C for 4 h. The pro-
tein was extracted using a protein extraction kit
according to the manufacturer’s protocol. Western blot-
ting was used to detect the expression levels of IL-1b
and TNF-a.
P2X4 receptor blocking in primary culture microglial cells
Primary culture microglial cells were prepared as
described above. Both PAADS (Sigma, Cat: P178, USA)
and TNP-ATP (Sigma, Cat: T4193, USA) were used for
blockade of P2X4. PAADS block P2X1-3, 5-7 receptors,
while TNP-ATP blocks P2X1-7 receptor selectively. By
comparing the blockade efficiency of the two blockers,
information on the role of P2X4 in regulation of AMC
activation is obtained [18,35].
PPADS at 30 μM and TNP-ATP at 20 μM were added
into the primary culture microglial cells, and incubated
for 2 h at 37°C in the chamber before hypoxia. After the
hypoxic exposure, the protein was collected from the
microglial cells for western blot analysis.
Western blotting
Briefly, proteins were extracted from primary cultured
microglial cells or postnatal rat brain tissue using a pro-
tein extraction kit (Biovision, Cat: K269-500, USA)
according to the manufacturer’s protocol. Cerebral tis-
sues containing the CC were rapidly removed and
immediately placed in dry ice before being stored at -80°
C until use. The brain tissue was gently homogenized in
ice-cold PBS (pH 7. 4) and centrifuged at 12000 g for 10
min at 4°C. The supernatant was recovered and frozen
at -80°C. Total protein was determined using a commer-
cial BCA kit (Pierce, IL, USA). Samples of supernatant
containing 25 μg of protein were heated to 95°C for 5
min and were separated by sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis in 12% gels, in a Mini-
Protein 3 apparatus (Bio-Rad Laboratories, Hercules,
CA, USA). After separation, proteins were transferred to
a polyvinylidene difluoride membrane (Minipore, Cat:
IPVH00010, USA) at 0. 8 mA/cm
2 of membrane for 2. 5
h in mixture solution of Tris-Glycine buffer (TBS) and
20% (v/v) methanol. After transfer, the membranes were
blocked with 5% non-fat dry milk in TBS-Tween 20 0.
1% (TBST) and incubated with rabbit anti-P2X4 (1:
400), rabbit anti-b-actin (1: 5000, Abcam, ab8227, USA),
rabbit anti-TNF-a polyclonal IgG (1: 500, Chemicon,
Cat: AB1837P, USA) and rabbit anti-IL-1b polyclonal
IgG(1: 500, Chemicon, Cat: AB1832P, USA) overnight,
at 4°C. The antibodies were detected using horseradish
peroxidase conjugated anti-rabbit IgG (1: 2500, KPL,
Cat: 14-13-06, USA) secondary antibody and visualized
using a chemiluminescence substrate system kit from
Super Signal West Pico (KPL, Cat: 54-61-00, USA) on
X-ray film (Super RX FujiFilm, Hanimax, QLD, Austra-
lia). Precision pre-stained standards (Bio-Rad Labora-
tories, Cat: 161-0376, USA) were used as molecular
weight markers. X-ray films were scanned to quantify
the band optical density using an Image J software
(National Institutes of Health, USA). Figures with the
quantitative western were derived from 6 animals from
each group and the hybridizations of each animal were
repeated at least 3 times.
Statistical analysis
A two tails Student’s t-test was used to determine the
statistical significance of difference in values between
the control and experimental preparations. A value of P
<0 .0 5o rP < 0. 01 was considered significant.
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